US2016042136A1PendingUtilityA1

Blood glucose management and interface systems and methods

Assignee: ROCHE DIABETES CARE INCPriority: Jun 29, 2009Filed: Oct 21, 2015Published: Feb 11, 2016
Est. expiryJun 29, 2029(~2.9 yrs left)· nominal 20-yr term from priority
Inventors:Henning Groll
G06T 11/26A61B 5/7435A61B 5/7475G06T 2210/41A61B 5/14532A61M 2230/201G01N 27/4163G16H 40/63G16H 10/65A61B 5/7425G06T 11/206G06F 19/3406
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A blood glucose management device is disclosed that is operable to seamlessly and sequentially provide a sequence of at least two displays of data relating to one or more blood glucose measurements to a user, upon minimal user interaction with the blood glucose management device.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
         1 . A portable blood glucose management device, comprising:
 a housing including a display and a user entry means for receiving user input;   a processor in the housing operatively connected to the display and the user entry means; and   a memory connected to the processor,   wherein the processor is configured to:   associate a plurality of blood glucose measurements that may be stored in the memory with a respective one of a number of context groups of blood glucose measurements that may be stored in the memory, and   seamlessly and sequentially produce on the display each of a sequence of a plurality of graphical representations of the context groups for a period of time automatically and without user input to the user input means, wherein each of the plurality of graphical representations is directed to blood glucose measurements in a different context group.   
     
     
         2 . The device of  claim 1 , further comprising a test strip port formed in the housing for receiving a test strip, wherein at least one of the plurality of blood glucose measurements comprises a current blood glucose measurement determined from a measurement performed on a blood sample provided to a test strip received within the test strip port, the processor being operable to perform said measurement and to store a current blood glucose measurement in the memory. 
     
     
         3 . The device of  claim 2 , wherein the processor also is configured to produce on the display a representation of the current blood glucose measurement and to associate the current blood glucose measurement with at least one blood glucose measurement in one of the number of context groups of blood glucose measurements stored in the memory, and wherein the processor further is configured to seamlessly produce on the display a graphical representation of the associated blood glucose measurements after displaying the current blood glucose measurement. 
     
     
         4 . The device of  claim 1 , wherein the device further comprises a data communications port in the housing, wherein at least one of the plurality of blood glucose measurements comprises a measurement result transferred from a second device and through the data communications port, the processor operable to receive the transferred result and to store the result in the memory. 
     
     
         5 . The device of  claim 1 , wherein the context groups include at least two or more of a fasting context group, a prandial context group, an exercise context group, a pre-sleep context group, an episodic testing context group, a pre-office visit context group, a glucose tolerance context group, an Average Daily Risk Ratio context group, and a predicted HbA1c context group. 
     
     
         6 . The device of  claim 1 , wherein processor also is operable to selectively pause and resume the seamless and sequential display of the graphical representations upon user input to the user entry means. 
     
     
         7 . The device of  claim 1 , wherein the processor is also configured to seamlessly produce on the display advice directed to a currently displayed one of the graphical representations upon user input into the user entry means. 
     
     
         8 . The device of  claim 7 , wherein the advice includes an interpretation of the blood glucose measurements in the currently displayed graphical representation relative to pre-defined blood glucose limits. 
     
     
         9 . The device of  claim 1 , wherein the plurality of graphical representations includes xy-graphs of blood glucose measurements in the context group for at least one of a seven day time period and a thirty day time period. 
     
     
         10 . The device of  claim 8 , wherein the advice includes a recommended dietary change. 
     
     
         11 . The device of  claim 1 , wherein the user entry means includes at least two buttons located adjacent to the display, and wherein the processor is further configured to assign a function to each of the at least two buttons and to produce the assigned functions on the display, and wherein the assigned functions depend on the graphical representation being currently produced on the display. 
     
     
         12 . The device of  claim 1 , wherein the user entry means includes at least two buttons, and the user input consists of one press of one button of the user entry means.

Join the waitlist — get patent alerts

Track US2016042136A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.